Skip to Main Content

Shylaja Srinivasan


Pediatric endocrinologist
Pediatric type 2 diabetes specialist in care and research

Dr. Shylaja Srinivasan is a pediatric endocrinologist who cares for children with thyroid or adrenal disorders, endocrine conditions related to growth and puberty, bone and calcium disorders, and type 1 or type 2 diabetes. She has a special interest in type 2 diabetes that develops in childhood, an increasingly common condition caused by a complex interplay between genetics and environment.

Srinivasan's research focuses on understanding the genetic factors in type 2 diabetes. Her research also explores the genetic basis for different responses to diabetes medications, particularly metformin.

Originally from Chennai in South India, Srinivasan earned her medical degree at the Pondicherry Institute of Medical Sciences. She completed residencies in pediatrics at SUNY Downstate Health Sciences University and Tufts Medical Center, followed by a Harvard Medical School fellowship in pediatric endocrinology at Massachusetts General Hospital.

In 2016, Srinivasan won the Pediatric Endocrine Society's Clinical Scholar Award, receiving a grant to pursue research in the genetics of type 2 diabetes. She is a member of the Pediatric Endocrine Society, Endocrine Society, American Diabetes Association and American Society of Human Genetics.

  • Education

    Pondicherry Institute of Medical Sciences, 2008

  • Residencies

    SUNY Downstate Health Sciences University, Pediatrics , 2012

    Tufts Medical Center, Pediatrics, 2013

  • Fellowships

    Massachusetts General Hospital, Pediatric Endocrinology, 2016

  • Board Certifications

    Pediatric Endocrinology, American Board of Pediatrics

    Pediatrics, American Board of Pediatrics

  • Academic Title

    Assistant Professor

  • Languages


I aim to provide excellent evidence-based, compassionate care to children and their families.

Where I see patients (2)

    Decorative Caduceus

    Continuous Glucose Monitoring System Feasibility in Youth With T2D

    Use of CGM measured by number of hours participants in the intervention arm wear the CGM device and view data on the mobile application.


    More about this study
    Decorative Caduceus

    Precision Dosing of Metformin in Youth With T2D

    The perception that a higher dose of Metformin is agreeable or satisfactory measured with the 4-item Acceptability of Intervention Measure (AIM). A 4-item measure of perceived intervention acceptability. Items are measured on a 5-...


    More about this study
    See all clinical trials

    Soothing the soul

    Our music therapy program nurtures patients with bedside serenades, rap workshops and more.

    Find out more